Robert Ross Carter

Insider Reports History

Location
Cerritos, CA
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Ross Carter:

Company Role Class Num Shares Value Price $ Report Date Ownership
Oncology Institute, Inc. Chief Financial Officer Common Stock 235,125 $862,908 $3.67 02 Jan 2026 Direct
Oncology Institute, Inc. Chief Financial Officer Class A Common Stock 235,174 $629,090 $2.68 21 May 2025 Direct
Oncology Institute, Inc. Chief Financial Officer Common Warrant 4,528 $566 $0.1250 26 Mar 2025 Direct

Insider Reports Filed by Robert Ross Carter

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TOI Oncology Institute, Inc. 02 Jan 2026 1 -$895 4/A Chief Financial Officer 06 Jan 2026, 16:30
TOI Oncology Institute, Inc. 17 Nov 2025 1 $0 4 Chief Financial Officer 19 Nov 2025, 18:00
TOI Oncology Institute, Inc. 21 May 2025 1 -$4,283 4 Chief Financial Officer 22 May 2025, 14:12
TOI Oncology Institute, Inc. 31 Mar 2025 1 $0 4 Chief Financial Officer 02 Apr 2025, 17:22
TOI Oncology Institute, Inc. 26 Mar 2025 2 +$10,000 4 Chief Financial Officer 28 Mar 2025, 17:27
TOI Oncology Institute, Inc. 19 Mar 2025 1 -$1,022 4 Chief Financial Officer 20 Mar 2025, 17:56
TOI Oncology Institute, Inc. 06 Jan 2025 1 -$86.43 4 Chief Financial Officer 07 Jan 2025, 13:18
TOI Oncology Institute, Inc. 20 Nov 2024 1 -$31.96 4 Chief Financial Officer 21 Nov 2024, 18:21
TOI Oncology Institute, Inc. 20 Sep 2024 0 $0 3 Chief Financial Officer 30 Sep 2024, 16:30